Stay updated on Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4. This represents a minor update to the page's revision history rather than a substantive content change.
    Difference
    0.0%
    Check dated 2026-05-17T09:42:07.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page footer revision marker was updated to **Revision: v3.5.3** (from **v3.5.2**), reflecting an interface/version change rather than any study-record information.
    Difference
    0.0%
    Check dated 2026-04-25T17:47:34.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:15:05.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    - Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-20T13:31:11.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T04:02:06.000Z thumbnail image
  9. Check
    105 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added; prior notice about government funding status (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T16:21:45.000Z thumbnail image

Stay in the know with updates to Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page.